(Q43712099)

26 November 2017

Protease activity in a hapten-induced model of ulcerative colitis in rats. (English)

1 reference

26 November 2017

1 reference

Hawkins JV

1

1 reference

26 November 2017

Emmel EL

2

1 reference

26 November 2017

Feuer JJ

3

1 reference

26 November 2017

Nedelman MA

4

1 reference

26 November 2017

Harvey CJ

5

1 reference

26 November 2017

Klein HJ

6

1 reference

26 November 2017

Rozmiarek H

7

1 reference

26 November 2017

Kennedy AR

8

1 reference

26 November 2017

Lichtenstein GR

9

1 reference

26 November 2017

Billings PC

10

1 reference

26 November 2017

1 September 1997

1 reference

Digestive Diseases and Sciences

26 November 2017

1 reference

26 November 2017

42

1 reference

26 November 2017

9

1 reference

26 November 2017

1969-1980

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1018887832465

26 November 2017

0 references

cites work

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

12 December 2020

Protease inhibitor suppression of colon and anal gland carcinogenesis induced by dimethylhydrazine.

1 reference

12 December 2020

Pancreatic and granulocytic endoproteases in faecal extracts from patients with active ulcerative colitis

1 reference

12 December 2020

Protease inhibitors in plasma and faecal extracts from patients with active inflammatory bowel disease

1 reference

12 December 2020

Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models

1 reference

12 December 2020

[Bowman-Birk soy inhibitor as an affinity ligand for isolating leukocyte elastase. Inhibition of elastin hydrolysis, catalyzed by leukocyte elastase]

1 reference

12 December 2020

Influence of inflammatory bowel disease on the distribution and concentration of pancreatic secretory trypsin inhibitor within the colon

1 reference

12 December 2020

The ability of hapten-conjugated cells to induce cell-mediated cytotoxicity is affected by the mode of hapten linkage

1 reference

12 December 2020

A growth-regulated protease activity that is inhibited by the anticarcinogenic Bowman-Birk protease inhibitor

1 reference

12 December 2020

Cytokines (immunoinflammatory hormones) and their natural regulation in inflammatory bowel disease (Crohn's disease and ulcerative colitis): a review

1 reference

12 December 2020

Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice.

1 reference

12 December 2020

An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis

1 reference

12 December 2020

A proteolytic activity in a human breast cancer cell line which is inhibited by the anticarcinogenic Bowman-Birk protease inhibitor

1 reference

12 December 2020

Inflammatory bowel disease (1)

1 reference

12 December 2020

[Inhibition of cathepsin G and elastase from human granulocytes by multiple forms of the Bowman-Birk type of soy inhibitor]

1 reference

12 December 2020

The drug 5-aminosalicylic acid rescues alpha 1-proteinase inhibitor from the neutrophil oxidative inactivation. A possible contribution to its therapeutic action in ulcerative colitis

1 reference

12 December 2020

Human fibroblasts contain a proteolytic activity which is inhibited by the Bowman-Birk protease inhibitor.

1 reference

12 December 2020

Treatment of ulcerative colitis with camostat mesilate, a serine protease inhibitor

1 reference

12 December 2020

Tissue destruction by neutrophils

1 reference

12 December 2020

Hapten-induced model of chronic inflammation and ulceration in the rat colon

1 reference

12 December 2020

Experimental models of inflammatory bowel disease

1 reference

12 December 2020

Oxidants and free radicals in inflammatory bowel disease

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1018887832465

1 reference

Dimensions Publication ID

26 November 2017

0 references

1 reference